| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1983Sci...222..765L |
| P356 | DOI | 10.1126/SCIENCE.6356357 |
| P698 | PubMed publication ID | 6356357 |
| P2093 | author name string | Stewart T | |
| Lenoir G | |||
| Murphy W | |||
| Taub R | |||
| Leder P | |||
| Battey J | |||
| Potter H | |||
| Moulding C | |||
| P433 | issue | 4625 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 765-771 | |
| P577 | publication date | 1983-11-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Translocations among antibody genes in human cancer | |
| P478 | volume | 222 |
| Q44950605 | A 5'-truncated c-myc gene variant not associated with a risk of cancer |
| Q38297366 | A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. |
| Q70569969 | A conserved sequence at c-myc oncogene chromosomal translocation breakpoints in plasmacytomas |
| Q72585718 | A genetic analysis of extinction: Trans-dominant loci regulate expression of liver-specific traits in hepatoma hybrid cells |
| Q41826773 | A negative transcriptional control element located upstream of the murine c-myc gene |
| Q33957035 | A novel intron element operates posttranscriptionally To regulate human N-myc expression |
| Q33542991 | A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype |
| Q35470134 | A novel transposon-like repeal interrupted by an LTR element occurs in a cluster of Bl repeats in the mouse c-moslocus |
| Q34351994 | A plasmacytoma-specific factor binds the c-myc promoter region |
| Q70228632 | A stably transfected c-myc cat hybrid gene is not regulated by serum in NIH3T3 cells |
| Q35602831 | A translocated human c-myc oncogene is altered in a conserved coding sequence |
| Q44375080 | A translocation t(8;14) and c-myc gene rearrangement associated with the histological transformation of B-cell acute lymphocytic leukemia (FAB-L2) into Burkitt's type (FAB-L3) leukemia |
| Q36821516 | A viral long terminal repeat expressed in CD4+CD8+ precursors is downregulated in mature peripheral CD4-CD8+ or CD4+CD8- T cells |
| Q45021537 | AID is required for c-myc/IgH chromosome translocations in vivo |
| Q37269390 | AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations |
| Q34328206 | AID-Targeting and Hypermutation of Non-Immunoglobulin Genes Does Not Correlate with Proximity to Immunoglobulin Genes in Germinal Center B Cells |
| Q33932184 | Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives |
| Q34857525 | Abnormal chromosome repair and risk of developing cancer |
| Q43708741 | Abrogation of IL-3 and IL-2 dependence by recombinant murine retroviruses expressing v-myc oncogenes |
| Q36890641 | Accurate and efficient transcription of human c-myc genes injected into Xenopus laevis oocytes |
| Q39826887 | Activation of proto-oncogenes in human leukemias |
| Q37690084 | Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma |
| Q40557556 | Alternate structures and stabilities of c-myc RNA in a bursal lymphoma cell line |
| Q40819123 | Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours |
| Q34339751 | Amplification and deregulation of MYC following Epstein-Barr virus infection of a human B-cell line |
| Q47918368 | Amplification of the translocated c-myc genes in three Burkitt lymphoma cell lines |
| Q69320814 | An (8;14)(q24;q11) translocation involving the T-cell receptor alpha-chain gene and the MYC oncogene 3' region in a B-cell lymphoma |
| Q40180340 | An approach to oncological genetics |
| Q36561988 | An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc |
| Q36887080 | Analysis of a transgenic mouse containing simian virus 40 and v-myc sequences |
| Q39831901 | Analysis of gene expression during hematopoiesis: present and future applications |
| Q36732014 | Analysis of premature termination in c-myc during transcription by RNA polymerase II in a HeLa nuclear extract |
| Q36099554 | Analysis of the 3' flanking region of the human c-myc gene in lymphomas with the t(8;22) and t(2;8) chromosomal translocations |
| Q35817599 | Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes |
| Q69610486 | Assignment of the human homologue of Pim-1, a mouse gene implicated in leukemogenesis, to the pter-q12 region of chromosome 6 |
| Q42832476 | Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product |
| Q37685874 | Avian myelocytomatosis virus immortalizes differentiated quail chondrocytes |
| Q36915093 | Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts |
| Q52510726 | Biallelic DNA rearrangements and deletions within the BCL-6 gene in B-cell non-Hodgkin's lymphoma |
| Q37568163 | Biological activities of v-myc and rearranged c-myc oncogenes in rat fibroblast cells in culture |
| Q36951697 | Burkitt lymphoma cell line carrying a variant translocation creates new DNA at the breakpoint and violates the hierarchy of immunoglobulin gene rearrangement |
| Q33835215 | Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features. |
| Q54438993 | C-myc gene binding factors in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE). |
| Q53551117 | C-myc transcript is induced in rat liver at a very early stage of regeneration or by cycloheximide treatment |
| Q33929683 | CSF-1-induced gene expression in macrophages: dissociation from the mitogenic response. |
| Q37042928 | Cancer Genes by Non-Homologous Recombination |
| Q38705301 | Cancer genes by illegitimate recombination |
| Q39695954 | Cancer genes generated by rare chromosomal rearrangements rather than activation of oncogenes |
| Q34611335 | Cancer genes: rare recombinants instead of activated oncogenes (a review). |
| Q50131936 | Carcinogens stimulate intrachromosomal homologous recombination at an endogenous locus in human diploid fibroblasts |
| Q37406232 | Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression |
| Q40161805 | Cellular Oncogenes and Multistep Carcinogenesis |
| Q41180587 | Cellular and molecular analysis of lymphoid development using Rag-deficient mice |
| Q24596448 | Characterization of a candidate bcl-1 gene |
| Q37689397 | Characterization of rate-controlling steps in vivo by use of an adjustable expression vector |
| Q39726566 | Chemically induced aneuploidy in mammalian cells: mechanisms and biological significance in cancer |
| Q38266781 | Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability |
| Q33932005 | Chromatin structure of the murine c-myc locus: implications for the regulation of normal and chromosomally translocated genes. |
| Q33931872 | Chromatin structure of transcriptionally active and inactive human c-myc alleles |
| Q35603098 | Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma |
| Q34189533 | Chromosomal sublocalization of the human p97 melanoma antigen |
| Q33680724 | Chromosomal translocation in T-cell leukemia line HUT 78 results in a MYC fusion transcript |
| Q33845011 | Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript |
| Q24531855 | Chromosome 8 breakpoint far 3' of the c-myc oncogene in a Burkitt's lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus |
| Q38043045 | Chromosome Translocation, B Cell Lymphoma, and Activation-Induced Cytidine Deaminase |
| Q62966978 | Chromosome instability in mutagen sensitive mutants of Neurospora |
| Q33931026 | Chromosome translocation activates heterogeneously initiated, bipolar transcription of a mouse c-myc gene |
| Q58420444 | Chromosome translocation can occur on either side of the c-myc oncogene in Burkitt lymphoma cells |
| Q33931387 | Chromosome translocations clustered 5' of the murine c-myc gene qualitatively affect promoter usage: implications for the site of normal c-myc regulation |
| Q41817335 | Chromosomes, genes, and cancer. |
| Q45019477 | Clonality of EBV-Induced Lymphoproliferative Diseases in Immune-Deficient Patients |
| Q36886353 | Cloning and sequencing of a c-myc oncogene in a Burkitt's lymphoma cell line that is translocated to a germ line alpha switch region |
| Q34559025 | Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation |
| Q36674026 | Cloning of a breakpoint cluster region at band 3q27 involved in human non-Hodgkin's lymphoma |
| Q34381392 | Cloning of the chromosome translocation breakpoint junction of the t(14;19) in chronic lymphocytic leukemia |
| Q48377324 | Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. |
| Q40567159 | Clustered somatic mutations in and around first exon of non-rearranged c-myc in Burkitt lymphoma with t(8;22) translocation |
| Q72234282 | Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach |
| Q59008253 | Complex lymphoid and epithelial thymic tumours in Thyl-myc transgenic mice |
| Q36779697 | Complex translocation disrupts c-myc regulation in a human plasma cell myeloma |
| Q53548575 | Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation |
| Q34326650 | Cooperation of c-raf-1 and c-myc protooncogenes in the neoplastic transformation of simian virus 40 large tumor antigen-immortalized human bronchial epithelial cells |
| Q37979892 | Cytogenetic abnormalities and molecular markers of acute lymphoblastic leukemia. |
| Q41725789 | Cytogenetics of Leukemia |
| Q33837385 | DNA analysis in human disease |
| Q42963330 | DNA inversions between short inverted repeats in Escherichia coli |
| Q34632656 | DNA segment containing C beta 1, a gene for the constant region of the beta chain of the T-cell antigen receptor, was inserted into chromosome 6 in cells from one patient with human T-cell leukemia |
| Q33984277 | Damage-induced recombination in the yeast Saccharomyces cerevisiae |
| Q59095440 | Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation |
| Q41757130 | Deregulation in trans of c-myc expression in immortalized human urothelial cells and in T24 bladder carcinoma cells |
| Q41505766 | Deregulation of immunoglobulin expression: is this the main cause of Burkitt's lymphoma? |
| Q36900352 | Deregulation of the c-myc oncogene in virus-induced thymic lymphomas of AKR/J mice |
| Q47632161 | Detection of the t(2;5)(p23;q35) chromosomal translocation in large B-cell lymphomas other than anaplastic large cell lymphoma |
| Q37548298 | Determination of the c-MYC DNA-binding site |
| Q41361716 | Diet, nutrition, and cancer. An update on a controversial relationship |
| Q33567440 | Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma |
| Q37684217 | Differential efficiencies of in vitro translation of mouse c-myc transcripts differing in the 5' untranslated region |
| Q37119930 | Dysfunctional homologous recombination mediates genomic instability and progression in myeloma |
| Q36719029 | Effect of nucleotide excision repair in human cells on intrachromosomal homologous recombination induced by UV and 1-nitrosopyrene |
| Q48389789 | Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma. |
| Q36786710 | Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. |
| Q37562186 | Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma |
| Q72597179 | Epidermal growth factor receptor expression in squamous cell lung carcinomas: an immunohistochemical and gene analysis in formalin-fixed, paraffin-embedded material |
| Q24311421 | Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein |
| Q41070713 | Establishment and characterization of a canine T-lymphoblastoid cell line derived from malignant lymphoma |
| Q42154559 | Establishment and characterization of mouse leukemia cell lines L615K and L7212K derived from transplantable murine leukemias maintained in China |
| Q40726842 | Evidence for involvement of calpain in c-Myc proteolysis in vivo. |
| Q44906156 | Evidence for two distinct c-src loci on human chromosomes 1 and 20 |
| Q39494403 | Evolution of tumours and the impact of molecular oncology |
| Q34585486 | Evolutionarily conserved regions of the human c-myc protein can be uncoupled from transforming activity |
| Q41595912 | Expression and amplification of the N-myc gene in primary retinoblastoma |
| Q36886108 | Expression and characterization of the human c-myc DNA-binding protein |
| Q41097403 | Expression of SV40 Large T Antigen Stimulates Reversion of a Chromosomal Gene Duplication in Human Cells |
| Q37528225 | Expression of cell-cycle-dependent genes in phytohemagglutinin-stimulated human lymphocytes |
| Q35611424 | Expression of cellular oncogenes in primary cells from human acute leukemias |
| Q40818267 | Expression of normal and translocated c-myc alleles in Burkitt's lymphoma cells: evidence for different regulation |
| Q70664029 | Expression of sequences related to c-myc in Entamoeba |
| Q36838691 | Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice |
| Q37577006 | Extreme instability of myc mRNA in normal and transformed human cells. |
| Q36898991 | Fine structure of the cottontail rabbit papillomavirus mRNAs expressed in the transplantable VX2 carcinoma |
| Q71994939 | Follicle-stimulating hormone transiently induces expression of protooncogene c-myc in primary Sertoli cell cultures of early pubertal and prepubertal rat |
| Q40715297 | Foundations in cancer research. Chromosomes and cancer: the evolution of an idea. |
| Q54613997 | Further implications of the territorial effects of genes: chromosomal translocation and oncogene activation. |
| Q35606067 | Gene encoding the alpha chain of the T-cell receptor is moved immediately downstream of c-myc in a chromosomal 8;14 translocation in a cell line from a human T-cell leukemia |
| Q36849617 | Gene expression of human DNA polymerase alpha during cell proliferation and the cell cycle |
| Q39692912 | Gene transfer into mice |
| Q36918561 | Generation of altered transcripts by retroviral insertion within the c-myb gene in two murine monocytic leukemias |
| Q41745779 | Genes involved in the determination of the rate of inversions at short inverted repeats |
| Q37042930 | Genetic Instability and Tumor Development |
| Q35614985 | Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas |
| Q39542352 | Genetic and cytogenetic changes in acute lymphoblastic leukemia |
| Q41889605 | Genetic systems to investigate regulation of oncogenes and tumour suppressor genes in Drosophila |
| Q68326553 | Genomic alterations of the c-myc protooncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinomas |
| Q37783548 | Genomic profiles in B cell lymphoma |
| Q36759140 | Germ line c-myc is not down-regulated by loss or exclusion of activating factors in myc-induced macrophage tumors. |
| Q36950793 | Growth-dependent synthesis of c-myc-encoded proteins: early stimulation by serum factors in synchronized mouse 3T3 cells |
| Q43050083 | Ha-ras restriction fragment length polymorphisms in colorectal cancer |
| Q43997265 | Hemopoietic lineage switch: v-raf oncogene converts Emu-myc transgenic B cells into macrophages |
| Q41728974 | Heterogeneous expression of proto-oncogenes in Hodgkin's disease derived cell lines |
| Q64380415 | High-affinity binding site for a specific nuclear protein in the human IgM gene |
| Q36760760 | Homologous plasmid recombination is elevated in immortally transformed cells |
| Q28299447 | Human N-myc is closely related in organization and nucleotide sequence to c-myc |
| Q38340510 | Human c-myc gene contains a regulatory site similar to consensus of interferon response sequence (IRS). |
| Q39668510 | Human cancer and cellular oncogenes |
| Q30495423 | Human chromosome 22. |
| Q24299897 | Human proto-oncogene N-myc encodes nuclear proteins that bind DNA |
| Q24336084 | Identification of Putative c-Myc-Responsive Genes: Characterization of rcl, a Novel Growth-Related Gene† |
| Q37385878 | Identification of a T-cell-specific transcriptional enhancer located 3' of C gamma 1 in the murine T-cell receptor gamma locus |
| Q70127641 | Identification of a c-myc oncogene lacking the exon 1 in the normal cells of a patient carrying a thyroid carcinoma |
| Q24310637 | Identification of c- MYC as a Target of the APC Pathway |
| Q41335376 | Identification of genes involved in growth autonomy of hematopoietic cells by analysis of factor-independent mutants |
| Q24531841 | Immunochemical detection of proteins related to the human c-myc exon 1 |
| Q39831938 | Implications of tumor progression on clinical oncology |
| Q70627282 | In vitro transcription of the c-myc first exon may be influenced by the extent of chromatin assembly |
| Q33670561 | In vitro-derived leukemic erythroid cell lines induced by a raf- and myc-containing retrovirus differentiate in response to erythropoietin |
| Q36398127 | Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc |
| Q37524356 | Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells |
| Q37391581 | Inducible overproduction of the mouse c-myc protein in mammalian cells |
| Q36945486 | Induction of a step in carcinogenesis that is normally associated with mutagenesis by nonmutagenic concentrations of 5-azacytidine |
| Q35593384 | Induction of c-myc expression in human B lymphocytes by B-cell growth factor and anti-immunoglobulin |
| Q36834908 | Induction of clonal monocyte-macrophage tumors in vivo by a mouse c-myc retrovirus: rearrangement of the CSF-1 gene as a secondary transforming event |
| Q33834457 | Inference of cancer-specific gene regulatory networks using soft computing rules |
| Q41834221 | Inhibition of polypeptide chain initiation in Daudi cells by interferons. Evidence that activity of initiation factor eIF-2 and availability of mRNA are unimpaired |
| Q37554814 | Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor |
| Q41674122 | Interaction of nuclear factors with the regulatory region of the N-myc gene during differentiation of human embryonal carcinoma cells |
| Q37678291 | Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level |
| Q33880694 | Intragenic pausing and anti-sense transcription within the murine c-myc locus |
| Q41588412 | Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation |
| Q34706941 | Isolation of cDNA clones for the chicken neural cell adhesion molecule (N-CAM) |
| Q28255448 | LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas |
| Q55062430 | Latterday lessons of lambda and lac. |
| Q37401701 | Localization of a lymphocyte-specific protein tyrosine kinase gene (lck) at a site of frequent chromosomal abnormalities in human lymphomas |
| Q36911274 | Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line |
| Q55006667 | Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas |
| Q28188372 | MM-1, a c-Myc-binding protein, is a candidate for a tumor suppressor in leukemia/lymphoma and tongue cancer |
| Q59072385 | Mammalian MYC Proteins and Cancer |
| Q43182555 | Mechanism of endogenous myc gene down-regulation in E mu-N-myc tumors |
| Q71367164 | Message of myc in context |
| Q37994937 | Molecular Logic Underlying Chromosomal Translocations, Random or Non-Random? |
| Q40896939 | Molecular basis of cancer: oncogenes and tumor suppressor genes |
| Q34680639 | Molecular causes of colon cancer |
| Q37398111 | Molecular cloning of the breakpoint junction of a human chromosomal 8;14 translocation involving the T-cell receptor alpha-chain gene and sequences on the 3' side of MYC. |
| Q39731092 | Molecular genetics of human B cell neoplasia |
| Q30498610 | Molecular mechanisms of cancer |
| Q36911215 | Multiple growth-associated nuclear proteins immunoprecipitated by antisera raised against human c-myc peptide antigens |
| Q36793456 | Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer |
| Q53544585 | Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations |
| Q28775977 | Mutagenesis of avian carcinoma virus MH2: only one of two potential transforming genes (delta gag-myc) transforms fibroblasts |
| Q37528796 | N-myc can cooperate with ras to transform normal cells in culture |
| Q33561040 | N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc |
| Q41233339 | Negative autoregulation of c-myc gene expression is inactivated in transformed cells |
| Q41206626 | Negative autoregulation of c-myc transcription |
| Q36839740 | Neoplastic transformation by the human gene N-myc |
| Q43407119 | Nonrandom loss of chromosome 15 in Syrian hamster tumours induced by v-Ha-ras plus v-myc oncogenes |
| Q36897540 | Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas |
| Q48388335 | Nucleotide sequence comparison of normal and translocated murine c-myc genes |
| Q37685772 | Nucleotide sequence of two overlapping myc-related genes in avian carcinoma virus OK10 and their relation to the myc genes of other viruses and the cell |
| Q36752903 | Oncogene cooperation in lymphocyte transformation: malignant conversion of E mu-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl |
| Q70098008 | Oncogenes |
| Q44714658 | Oncogenes and cancer |
| Q39695652 | Oncogenes and their role in human neoplasia |
| Q59064920 | Oncogenes:Regulation and activation of c-myc |
| Q59085650 | Oncogenesis: Paradox and paradigm: the message and meaning of myc |
| Q35977137 | Over-expression of the c-myc proto-oncogene in colorectal carcinoma |
| Q38956273 | Pediatric T-cell acute lymphoblastic leukemia |
| Q42572125 | Proto-oncogene c-myc is expressed in cerebellar neurons at different developmental stages |
| Q41403307 | Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas |
| Q24614782 | Proviral integration site Mis-1 in rat thymomas corresponds to the pvt-1 translocation breakpoint in murine plasmacytomas |
| Q48056177 | Quantification of hprt gene deletions mediated by illegitimate V(D)J recombination in peripheral blood cells of humans |
| Q36925736 | Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3' untranslated sequences |
| Q36833755 | Rearrangement and expression of erythropoietin genes in transformed mouse cells |
| Q59064462 | Rearrangement and transcription of the β-chain genes of the T-cell antigen receptor in different types of murine lymphocytes |
| Q40670672 | Rearrangement at the 5' end of amplified c-myc in human COLO 320 cells is associated with abnormal transcription |
| Q40817665 | Rearrangement between ornithine decarboxylase and the switch region of the gamma 1 immunoglobulin gene in alpha-difluoromethylornithine resistant mouse myeloma cells |
| Q36843944 | Rearrangement of rat immunoglobulin E heavy-chain and c-myc genes in the B-cell immunocytoma IR162. |
| Q24617887 | Rearrangements of the tal-1 locus as clonal markers for T cell acute lymphoblastic leukemia |
| Q40650315 | Recessive genetic deregulation abrogates c-myc suppression by interferon and is implicated in oncogenesis |
| Q56902268 | Recombination and its roles in DNA repair, cellular immortalization and cancer |
| Q47870805 | Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment |
| Q36557058 | Regulation of AID, the B-cell genome mutator |
| Q34519721 | Regulation of C-myc expression during growth and differentiation of normal and leukemic human myeloid progenitor cells |
| Q52520921 | Regulation of heat shock protein 70 gene expression by c-myc |
| Q40676274 | Regulation of the human c-myc gene: 5' noncoding sequences do not affect translation |
| Q35588621 | Regulation of translocated c-myc genes transfected into plasmacytoma cells |
| Q39456762 | Repression of c-myc is necessary but not sufficient for terminal differentiation of B lymphocytes in vitro |
| Q37419452 | Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes |
| Q39494206 | Retroviruses and human cancer: evaluation of T-lymphocyte transformation by human T-cell leukemia-lymphoma virus |
| Q33591714 | Role of the translocation partner in protection against AID-dependent chromosomal translocations |
| Q96224610 | SAMHD1-mediated dNTP degradation is required for efficient DNA repair during antibody class switch recombination |
| Q35591058 | Secondary activation of c-abl may be related to translocation to the nucleolar organizer region in an in vitro cultured rat leukemia cell line (K3D) |
| Q24651262 | Sequence analysis of the MYC oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered |
| Q36900400 | Sequences involved in accurate and efficient transcription of human c-myc genes microinjected into frog oocytes |
| Q24556540 | Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia |
| Q72386147 | Solid tumors of children: Chromosome abnormalities and the development of cancer |
| Q40191686 | Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants |
| Q36351344 | Spontaneous loss and alteration of antigen receptor expression in mature CD4+ T cells |
| Q42939811 | Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice |
| Q55133920 | Strain dependency of cell-type specificity and onset of lymphoma development in Emu-myc transgenic mice |
| Q55045874 | Strain-dependency of chromosomal abnormalities in lymphomas developed in E mu-myc transgenic mice. |
| Q33883089 | Streamlined approach to creating yeast artificial chromosome libraries from specialized cell sources |
| Q35939969 | Strong transcriptional activation of translocated c-myc genes occurs without a strong nearby enhancer or promoter |
| Q24594559 | Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia |
| Q36587310 | Structure of the polymorphic feline c-myc oncogene locus |
| Q41529671 | Surface IgM mediated regulation of RAG gene expression in E mu-N-myc B cell lines |
| Q36896486 | Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells |
| Q100958576 | Systematic investigation of promoter substitutions resulting from somatic intrachromosomal structural alterations in diverse human cancers |
| Q69348997 | T cell receptor gene rearrangement and expression in ataxia-telangiectasia B lymphoblastoid cells |
| Q37412708 | T-cell receptor alpha-chain gene is split in a human T-cell leukemia cell line with a t(11;14)(p15;q11). |
| Q39595329 | The arrangement of immunoglobulin and T cell receptor genes in human lymphoproliferative disorders. |
| Q36766445 | The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation |
| Q57338722 | The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice |
| Q41381676 | The chromatin structure of Rous sarcoma proviruses is changed by factors that act in trans in cell hybrids |
| Q38496502 | The emerging complexity of gene fusions in cancer |
| Q33881231 | The first exon of the c-myc proto-oncogene contains a novel positive control element. |
| Q40177695 | The genotoxic/epigenetic distinction: Relevance to cancer policy |
| Q56903271 | The homeodomain region of Rag-1 reveals the parallel mechanisms of bacterial and V(D)J recombination |
| Q24567492 | The human L-myc gene is expressed as two forms of protein in small cell lung carcinoma cell lines: detection by monoclonal antibodies specific to two myc homology box sequences |
| Q39499415 | The molecular action of platelet-derived growth factor |
| Q37580071 | The protein encoded by the human proto-oncogene c-myc |
| Q21093165 | The role of EBV in the pathogenesis of Burkitt's Lymphoma: an Italian hospital based survey |
| Q39818292 | The role of c-myc in the proliferation of normal and neoplastic cells |
| Q40594002 | The role of mitotic recombination in carcinogenesis |
| Q39751174 | The technique of premature chromosome condensation to study the leukemic process: review and speculations |
| Q37686525 | The translocated c-myc oncogene of Raji Burkitt lymphoma cells is not expressed in human lymphoblastoid cells |
| Q57084677 | Theoretical model for the post-transcriptional regulation of the human c-myc gene expression, involving double-stranded RNA processing |
| Q34355349 | Therapeutic strategies to inhibit MYC |
| Q37404148 | Trans-acting elements modulate expression of the human c-myc gene in Burkitt lymphoma cells |
| Q36913110 | Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype |
| Q40419300 | Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression |
| Q33640664 | Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model |
| Q36956860 | Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors |
| Q36949121 | Translational Efficiency of cMyc mRNA in Burkitt Lymphoma Cells |
| Q36261532 | Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells |
| Q37566467 | Translocation and rearrangement of c-myc into immunoglobulin alpha heavy chain locus in primary cells from acute lymphocytic leukemia |
| Q42567576 | Translocation of c-myc into the immunoglobulin heavy-chain locus in human acute B-cell leukemia. A molecular analysis |
| Q34405431 | Translocations involving c-myc and c-myc function |
| Q40463180 | Trasiocation affects normalc-mycpromoter usage and activates fifteen crypticc-myctranscription starts in plasmacytoma M603 |
| Q41433742 | Truncation of exon 1 from the c-myc gene results in prolonged c-myc mRNa stability |
| Q40131234 | Tumor progression in murine leukemia virus-induced T-cell lymphomas: monitoring clonal selections with viral and cellular probes |
| Q59079278 | Tumour development: Oncogenes in transgenic mice |
| Q33670203 | Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network |
| Q36783817 | Two distinct mechanisms of transcriptional control operate on c-myc during differentiation of HL60 cells |
| Q39825010 | Use of cultured human tissues and cells in carcinogenesis research |
| Q57338725 | Variant (6 ; 15) translocation in a murine plasmacytoma occurs near an immunoglobulin κ gene but far from the myc oncogene |
| Q24555810 | Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene |
| Q59096775 | Viral transduction of c-myc gene in naturally occurring feline leukaemias |
| Q34605992 | Viral-mediated noisy gene expression reveals biphasic E2f1 response to MYC |
| Q37929975 | What causes lymphocytic tumors? |
| Q34662891 | What retroviruses teach us about the involvement of c-Myc in leukemias and lymphomas |
| Q47989595 | Wild-type sequence of MYCN in neuroblastoma cell lines |
| Q39830472 | c-myc gene is transcribed at high rate in G0-arrested fibroblasts and is post-transcriptionally regulated in response to growth factors |
| Q37527764 | c-myc mRNA levels in the cell cycle change in mouse erythroleukemia cells following inducer treatment |
| Q41830956 | c-myc protein distribution. Neoplastic tissues of the human colon |
| Q38609261 | c-myc protooncogene expression in mouse erythroleukemia cells |
| Q36909626 | c-myc regulation during retinoic acid-induced differentiation of F9 cells is posttranscriptional and associated with growth arrest |
| Q37551357 | c-src is consistently conserved in the chromosomal deletion (20q) observed in myeloid disorders |
| Q36792001 | cis-acting translational effects of the 5' noncoding region of c-myc mRNA. |
| Q37511853 | myc family oncogenes in the development of normal and neoplastic cells. |
Search more.